Topic: spinal cord stimulation
Nevro got a CE mark for a new version of its SCS therapy for chronic pain.
Mebias presented rat data showing its mu opioid drugs could become a weapon in the scramble to combat the opioid epidemic.
The FDA cleared Medtronic's latest spinal cord stimulation system for the treatment of chronic intractable pain.
Stimwave scored FDA clearance for its tiny, injectable, MRI-safe neurostimulator for chronic peripheral nerve pain.
Saluda Medical has raised $40 million in a round led by a GSK's bioelectronic medicine VC fund.
Nevro is filing a patent infringement suit against Boston Scientific, which had its own patent suit against Nevro dismissed almost a year ago.
Just one week after bagging a CE mark for its MRI-compatible CRT pacemaker, St. Jude Medical announced an FDA full-body MRI label for its recharge-free spinal cord stimulation system.
The FDA approved St. Jude Medical’s physician-designed spinal cord stimulation system for the treatment of chronic pain.
Nevro is celebrating positive long-term data from a pivotal study of its spinal cord stimulation therapy for chronic pain. The news marks a bright point for the California med tech as it struggles with reimbursement for its device.